VALIDATION OF THE ROMANIAN VERSION OF MULTIPLE SCLEROSIS QUALITY OF LIFE (MSQOL-54) INSTRUMENT

Authors

  • A. CIUBOTARU “Grigore T. Popa” University of Medicine and Pharmacy Iași
  • I. LOGHIN “Grigore T. Popa” University of Medicine and Pharmacy Iași
  • Ghe. ANDRONIC “Grigore T. Popa” University of Medicine and Pharmacy Iași
  • Silvia PATRASC “Grigore T. Popa” University of Medicine and Pharmacy Iași
  • Ioana TAGA “Grigore T. Popa” University of Medicine and Pharmacy Iasi, Romania
  • B. IGNAT “Grigore T. Popa” University of Medicine and Pharmacy Iași
  • Doina AZOICAI “Grigore T. Popa” University of Medicine and Pharmacy Iasi, Romania

Keywords:

MULTIPLE SCLEROSIS, DEMYELINATING DISEASE, MSQOL54, VALIDATION PROCESS

Abstract

Aim: To validate the Romanian version of MSQOL questionnaire. Material and methods: The questionnaire was translated and culturally adapted in the Romanian space for the Romanian population and the questionnaire was validated in 50 patients with multiple sclerosis (MS) at the Neurology Clinic at of the Iasi Rehabilitation Hospital. The following indicators were analyzed: Cronbach’s alpha coefficient, Pearson’s (r) correlation coefficient, used to investigate the relationship between the composite scores and the main clinical and demographic variables, and the Bartlett Sphericity Test, which shows the correlation between the questionnaire items. Results: The psychometric standards met, and the general demographic data are illustrated by the following results. The group consisted of 50 patients, 35 women (70.0%) and 15 men (30.0%), mean age 39.76 ± 10.493 years, age range 18 to 65 years old, with no significant gender differences between the sexes (p = 0.627). Significance level of the Bartlett Sphericity Test, p = .000 - which shows that the items in of the questionnaire are correlated with each other. The Pearson correlation coefficients, all correlation coefficients obtained are statistically significant and moderate or strong in intensity. Median EDSS score was 3 in women, 4 in men, total score was 3. Conclusions: From now on, this adequate psychometric questionnaire will which allows an accurate measurement of quality of life (QoL) in MS patients with multiple sclerosis which is from now will be available for all medical professionals dealing with MS patients in Romania.

Author Biographies

  • A. CIUBOTARU, “Grigore T. Popa” University of Medicine and Pharmacy Iași

    Faculty of Medicine
    Department of Medical Specialties (III)

  • I. LOGHIN, “Grigore T. Popa” University of Medicine and Pharmacy Iași

    Faculty of Medicine
    Department of Surgery (I)

  • Ghe. ANDRONIC, “Grigore T. Popa” University of Medicine and Pharmacy Iași

    Faculty of Medicine
    Department of Medical Specialties (I)

  • Silvia PATRASC, “Grigore T. Popa” University of Medicine and Pharmacy Iași

    Faculty of Medicine
    Department of Medical Specialties (III)

  • Ioana TAGA, “Grigore T. Popa” University of Medicine and Pharmacy Iasi, Romania

    Faculty of Medicine
    Department of Medical Specialties (III)

  • B. IGNAT, “Grigore T. Popa” University of Medicine and Pharmacy Iași

    Faculty of Medicine
    Department of Medical Specialties (III)

  • Doina AZOICAI, “Grigore T. Popa” University of Medicine and Pharmacy Iasi, Romania

    Faculty of Medicine
    Department of Preventive Medicine and Interdisciplinarity

References

1. Roger P, Michael J, David A, et al. Clinical Neurology. United States: Lange, 2018, 235-237.
2. Cohen JA, Rae-Grant A. Handbook of multiple sclerosis. Springer Healthcare, 2012, 1-85.
3. Kalincik T. Multiple Sclerosis Relapses: Epidemiology. Outcomes and Management. A Systematic Review. Neuroepidemiology 2015; 44(4): 199-214 / doi: 10.1159/000382130.
4. Popescu B. Băjenaru O. Elemente esenţiale de neurologie clinică. Bucureşti: Editura Medicală Almatea, 2009: 200-201.
5. Pfenning L, Van der Ploeg HM, Cohen L CH, et al. A health-related quality of life questionnaire for multiple sclerosis patients. Acta Neurol Scand 1999; 100: 148-155.
6. Di Fabio RP, Choi T, Soderberg J, et al. Health-related quality of life for patients with progressive multiple sclerosis: influence of rehabilitation. Phys Ther 1997; 77: 1704-1716.
7. Miller A. Dishon S. Health-related quality of life in multiple sclerosis: Psychometric analysis of inventories. Multiple Sclerosis 2005; 11(4): 450-458.
8. Vickrey B, Hays R, Harooni R, et al. A health-related quality of life measure for multiple sclerosis. Quality of Life Research 1995; 4(3): 187-206 / doi: 10.1007/BF02260859.
9. Bland JM. Altman DG. Cronbach’s alpha. BMJ 1997; 314(7080): 572-573.
10. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 144-152.
11. Riwanti E, Syarly M, Agung Kusumawardhani, et al. Validation of the Indonesian version of multiple sclerosis quality of life-54 (MSQOL-54 INA) questionnaire. Health Qual Life Outcomes 2019; 17(1): 120 / doi: 10.1186/s12955-019-1190-1.
12. Egemen I, Fatma U, Serkan O, et al. Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample. J Neurol Sci 2006; 240(1-2): 77-80 / doi: 10.1016/j.jns.2005.09.009.
13. Tarik C, Josip C, Enra S, et al. Validation of the Disease-specific Questionnaire MSQOL-54 in Bosnia and Herzegovina Multiple Sclerosis Patients Sample. Med Arch 2017; 71(2): 103-106 / doi: 10.5455/medarh.2017.71.103-106.

Additional Files

Published

2022-12-27

Issue

Section

PREVENTIVE MEDICINE - LABORATORY